Literature DB >> 32378496

Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice.

S S Zulu1, O Abboussi2, N Simola3, M V Mabandla1, W M U Daniels4.   

Abstract

OBJECTIVES: Growing evidence suggested that antiretroviral (ARV) drugs may promote amyloid beta (Aβ) accumulation in HIV-1-infected brain and the persistence of HIV-associated neurocognitive disorders (HANDs). It has also been shown that lipid peroxidation upregulates β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) expression and subsequently promotes Aβ peptide production. In the present study, we examined whether chronic exposure to the anti-HIV drugs tenofovir disoproxil fumarate (TDF) and nevirapine induces lipid peroxidation thereby promoting BACE1 and Aβ generation and consequently impair cognitive function in mice.
METHODS: TDF or nevirapine was orally administered to female BALB/c mice once a day for 8 weeks. On the 7th week of treatment, spatial learning and memory were assessed using the Morris water maze test. The levels of lipid peroxidation, BACE1, amyloid β 1-42 (Aβ1-42) and Aβ deposits were measured in the hippocampal tissue upon completion of treatment.
RESULTS: Chronic administration of nevirapine induced spatial learning and memory impairment in the Morris water maze test, whereas TDF did not have an effect. TDF and nevirapine administration increased hippocampal lipid peroxidation and Aβ1-42 concentration. Nevirapine further upregulated BACE1 expression and Aβ deposits.
CONCLUSION: Our results suggest that chronic exposure to TDF and nevirapine contributes to hippocampal lipid peroxidation and Aβ accumulation, respectively, as well as spatial learning and memory deficits in mice even in the absence of HIV infection. These findings further support a possible link between ARV drug toxicity, Aβ accumulation and the persistence of HANDs.

Entities:  

Keywords:  HIV-associated cognitive motor complex; amyloid; beta-secretase; oxidative stress; reverse transcriptase inhibitors

Mesh:

Substances:

Year:  2020        PMID: 32378496     DOI: 10.1017/neu.2020.19

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  2 in total

1.  Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV.

Authors:  Jacinta Murray; Gregory Meloni; Etty P Cortes; Ariadna KimSilva; Michelle Jacobs; Alyssa Ramkissoon; John F Crary; Susan Morgello
Journal:  Acta Neuropathol Commun       Date:  2022-05-07       Impact factor: 7.578

2.  Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment.

Authors:  Ronald J Ellis; Ahmed Chenna; Christos J Petropoulos; Yolanda Lie; Dusica Curanovic; Melanie Crescini; John Winslow; Erin Sundermann; Bin Tang; Scott L Letendre
Journal:  J Neurovirol       Date:  2022-06-08       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.